Clinical Trial Update: AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma [NA]

View source ↗

Summary

This report summarizes a completed clinical trial evaluating the AqueSys XEN 45 glaucoma implant for refractory glaucoma, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• XEN 45 Gel Stent (XEN Gel Stent)

Snippet

Sponsor: AqueSys, Inc. | Conditions: Glaucoma, Glaucoma, Open Angle | NA | Status: COMPLETED | Results posted: 2017-06-01